INDIGO - vorisidenib is a problematic study that misuses crossover, as Haslam & I defined in 2016, and is not suitable to change practice

Miguel Zugman spent time at UCSF Epidemiology & Biostatistics & did this nice paper
Check it out
authors.elsevier.com/a/1ixfW7tJEDVw…

🔥Just published in Journal of Urology
1️⃣The first US RCT on prophylactic mesh in ileal conduit led by Dr. Hooman Djaladat (2015-2023)
▶️Biologic mesh placement is feasible with no AEs
▶️No protective effect within 2yr FU
🔗auajournals.org/doi/10.1097/JU…
Amer. Urol. Assn. USC Urology Radiology of USC

Postoperative incentive spirometry is a scam

(Hospitals should take all the money they spend on those little spirometers and spend it on early ambulation resources instead!)

Tribute to the European Association of Urology (EAU) leadership including Kari Tikkinen Alberto Briganti for setting aside time/space for session on EBCP and guidelines with international speakers Rod Breau Daniel A. González-Padilla Edouard Philippe Philippe Violette @AlbertoMartini Angie Puerto Nino Nick James

#EAU24

Cerrar las centrales nucleares es un suicidio energético.

If you are into evidence based medicine and/or critical lecture of the literature, you cannot miss this session at #EAU24 in Paris 🇫🇷.

For those wondering how MDPI 'special issues' work.

If you work hard enough to get other Colleagues to spend their money they could even get a fake book with ISBN code!

Outrageous.

Universities should ban these tricks.

We devised a new way to let researchers use patient's confidential medical records in research, while ALSO preserving their privacy.

How does OpenSAFELY work?

We made a 5 minute video!

youtube.com/watch?v=GRjRqO…

Elevate your surgical skills to the next level!
Our #PartialNephrectomy training models are here to help.
Affordable, effective, and ready for you.

Learn more: urology3d.com #TrainingForEveryone #urology3D

Ricardo Brime Esther Garcia Rojo

8-3 vote on a IDA Cel
Drug doesn't improve survival
Clearly OS curves look like they will never be positive
Tons of toxicity, early death
Astonishingly low standards in Cancer medicine

🤖 So #ChatGPT wrote the first sentence of this Elsevier article. Any other parts of the article too? How come none of the coauthors, Editor-in-Chief, reviewers, typesetters noticed? How can this happen with regular peer-review? pubpeer.com/publications/C…

Amazing paper showing the very low aggressiveness of Gleason 6 cancer.

auajournals.org/doi/10.1097/JU…

Great piece by Gilbert Welch on lung cancer screening.

thelancet.com/journals/lanre…

Great summary of the Peyronie guidelines from ESSM.

Impressively wide ranges of success/satisfaction/complications-harms

Satisfaction with plicsrion can be as low as 58% and recurrence risk from 0.5 to 55%.

Numbers all over the place.

Very useful summary

Es la era de los GLP1-ra para el tratamiento de la #obesidad , pero el #EJERCICIO es 🔑: potencia la pérdida de peso, y previene su recuperación tras detener el fármaco. Este estudio 🆓doi.org/10.1016/j.ecli… resalta al ejercicio como equiparable en importancia a los medicamentos

Our meta-analysis evaluating impact of ARSI therapy for #prostatecancer on falls & fractures 🦴 finally out in European Urology Oncology

Link: authors.elsevier.com/sd/article/S25…

Craig Jones Struan Gray Mick Brown 🇮🇳 Bhavan Rai 🇬🇧

GU Cancer Research group Division of Cancer Sciences

For a second, I thought we were scooped!
Whew!
In our recent paper, led by Timothée Olivier, MD, we explore a new challenge in censoring
Equal rates of censoring but for different reasons.
Such censoring can still be informative, i.e. bias results
Especially 4 PFS
Manni Mohyuddin

Testing the paper Abstract using GPTZero the probability that it was generated by AI is 97%. 𝑶𝒏𝒍𝒚 𝒐𝒏 Frontiers 🤖⬇️